Free Trial

Processa Pharmaceuticals (PCSA) SEC Filings & 10K Form

Processa Pharmaceuticals logo
$0.87 +0.03 (+4.04%)
(As of 03:33 PM ET)

Recent Processa Pharmaceuticals SEC Filings

DateFilerForm TypeView
12/20/2024
3:31 PM
Processa Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/02/2024
3:36 PM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2024
3:50 PM
Pannu Geraldine (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:51 PM
Processa Pharmaceuticals (Issuer)
Yorke Justin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:47 PM
Baluch Khoso (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:48 PM
Neal James R (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2024
7:00 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:15 PM
Processa Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2024
4:28 PM
Lin Patrick (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2024
4:31 PM
Processa Pharmaceuticals (Issuer)
Stanker James H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2024
4:34 PM
Bigora Sian (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2024
4:09 PM
Processa Pharmaceuticals (Issuer)
Young David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
7:00 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2024
4:59 PM
Processa Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/18/2024
3:42 PM
Processa Pharmaceuticals (Issuer)
SKIBSTED RUSSELL (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2024
3:46 PM
Processa Pharmaceuticals (Issuer)
SKIBSTED RUSSELL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2024
7:00 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
1:19 PM
Processa Pharmaceuticals (Filer)
Form DEFR14A
05/28/2024
11:15 PM
Processa Pharmaceuticals (Filer)
Form EFFECT
05/28/2024
3:49 PM
Processa Pharmaceuticals (Filer)
Form 424B5
05/21/2024
3:13 PM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2024
3:57 PM
Processa Pharmaceuticals (Issuer)
Stanker James H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
4:01 PM
Processa Pharmaceuticals (Issuer)
Young David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
3:50 PM
Guy Wendy (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
3:52 PM
Bigora Sian (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
3:55 PM
Lin Patrick (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2024
7:00 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2024
11:05 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/21/2024
4:25 PM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2024
3:22 PM
Processa Pharmaceuticals (Issuer)
Young David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2024
7:30 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/01/2024
5:32 PM
Lin Patrick (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:34 PM
Processa Pharmaceuticals (Issuer)
Yorke Justin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:37 PM
Ng George K (Reporting)
Processa Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
9:46 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2024
11:15 PM
Processa Pharmaceuticals (Filer)
Form EFFECT
01/25/2024
7:35 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
7:00 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/18/2024
7:30 AM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
3:30 PM
Processa Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
7:55 AM
Processa Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
Wall St. Icon: “If you wait on this, it will already be too late” (Ad)

If you have a significant amount of money in the stock market right now — or if you're sitting on the sidelines waiting to make a move — you DO NOT want to miss my latest research.

Go here now to see my urgent warning
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PCSA) was last updated on 12/24/2024 by MarketBeat.com Staff
From Our Partners